Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

NCT05929664 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Basal Cell Carcinoma
Basal Cell Carcinoma

Interventions

BIOLOGICAL: Cemiplimab
PROCEDURE: Computed Tomography
PROCEDURE: Biospecimen Collection
OTHER: Quality-of-Life Assessment
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Biopsy
BIOLOGICAL: Fianlimab

Sponsor

Thomas Jefferson University

Collaborators

Regeneron Pharmaceuticals